ArticleAmerican heart journal plus : cardiology research and practice2022

The association of fibroblast growth factor 23 at mid-life and late-life with subsequent risk of cardiovascular disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Yasuyuki Honda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.